Benchmark Holdings (DB:31B) - Aandelenkoers, Nieuws & Analyse

31B Overzicht aandelen

31B fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	4/6
Prestaties in het verleden	0/6
Financiële gezondheid	5/6
Dividenden	0/6

Beloningen

Verhandeld tegen 45.4% onder onze schatting van de reële waarde

De winst zal naar verwachting met 119.48% per jaar groeien

Risicoanalyse

Volatiele aandelenkoers in de afgelopen 3 maanden

Benchmark Holdings plc Concurrenten

FRoSTA

DB:NLM

€408.8m

Südwestdeutsche Salzwerke

DB:SSH

€630.5m

Schwälbchen Molkerei Jakob Berz

DB:SMB

€55.8m

Südzucker

XTRA:SZU

€2.3b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Benchmark Holdings
Historische aandelenkoersen
Huidige aandelenkoers	UK£0.42
52 Week Hoogtepunt	UK£0.53
52 Week Laag	UK£0.35
Bèta	0.70
11 maand verandering	-9.40%
3 maanden verandering	1.44%
1 Jaar Verandering	6.53%
33 jaar verandering	-41.11%
5 jaar verandering	-22.63%
Verandering sinds IPO	-36.05%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	31B	DE Food	DE Markt
7D	1.4%	-1.0%	-0.6%
1Y	6.5%	-11.2%	9.6%

Rendement versus industrie: 31B overtrof de German Food industrie, die het afgelopen jaar een rendement -11.2 % opleverde.

Rendement versus markt: 31B presteerde slechter dan German Market, dat het afgelopen jaar een rendement van 9.6 % opleverde.

Prijsvolatiliteit

Is 31B's price volatile compared to industry and market?
31B volatility
31B Average Weekly Movement	7.7%
Food Industry Average Movement	3.8%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.0%
10% least volatile stocks in DE Market	2.4%

Stabiele aandelenkoers: De aandelenkoers van 31B is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 8% ) van 31B is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen German.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2000	823	Trond Williksen	www.benchmarkplc.com

Benchmark Holdings plc houdt zich, samen met haar dochterondernemingen, bezig met het leveren van technische diensten, producten en specialistische kennis die de ontwikkeling van de voedsel- en landbouwindustrie ondersteunen. Het bedrijf is actief in de segmenten Genetica, Geavanceerde Voeding en Gezondheid. Het segment Genetica biedt kweektechnologieën en productiefaciliteiten voor zeebaars en -brasem, zalm en garnalen aan de tuigindustrie om eicellen van verschillende genetische verdiensten te leveren.

Benchmark Holdings plc Samenvatting

Hoe verhouden de winst en inkomsten van Benchmark Holdings zich tot de beurswaarde?
31B fundamentele statistieken
Marktkapitalisatie	€328.71m
Inkomsten(TTM)	-€34.76m
Inkomsten(TTM)	€177.38m

1.9x

P/S-verhouding

-9.5x

Koers/Winstverhouding

Is 31B overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
31B resultatenrekening (TTM)
Inkomsten	UK£147.51m
Kosten van inkomsten	UK£72.72m
Brutowinst	UK£74.79m
Overige uitgaven	UK£103.69m
Inkomsten	-UK£28.91m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 29, 2024

Winst per aandeel (EPS)	-0.039
Brutomarge	50.70%
Nettowinstmarge	-19.60%
Schuld/Eigen Vermogen Verhouding	31.9%

Hoe presteerde 31B op de lange termijn?

Bekijk historische prestaties en vergelijking

31B Overzicht aandelen

Beloningen

Risicoanalyse

Benchmark Holdings plc Concurrenten

DB:NLM

€408.8m

DB:SSH

€630.5m

DB:SMB

€55.8m

XTRA:SZU

€2.3b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Third quarter 2024 earnings released: UK£0.013 loss per share (vs UK£0.007 loss in 3Q 2023)

Second quarter 2024 earnings released: UK£0.002 loss per share (vs UK£0.004 loss in 2Q 2023)

First quarter 2024 earnings released: UK£0.01 loss per share (vs UK£0.002 loss in 1Q 2023)

Benchmark Holdings plc to Report Q4, 2024 Results on Nov 27, 2024

Benchmark Holdings plc Announces Directorate Change

Benchmark Holdings plc, Annual General Meeting, Feb 08, 2024

Recent updates

Third quarter 2024 earnings released: UK£0.013 loss per share (vs UK£0.007 loss in 3Q 2023)

Second quarter 2024 earnings released: UK£0.002 loss per share (vs UK£0.004 loss in 2Q 2023)

First quarter 2024 earnings released: UK£0.01 loss per share (vs UK£0.002 loss in 1Q 2023)

Benchmark Holdings plc to Report Q4, 2024 Results on Nov 27, 2024

Benchmark Holdings plc Announces Directorate Change

Benchmark Holdings plc, Annual General Meeting, Feb 08, 2024

Full year 2023 earnings released: UK£0.024 loss per share (vs UK£0.046 loss in FY 2022)

Benchmark Holdings plc Announces Changes to its Board

Third quarter 2023 earnings released: UK£0.007 loss per share (vs UK£0.019 loss in 3Q 2022)

Benchmark Holdings plc Announces Board Changes

Second quarter 2023 earnings released: UK£0.004 loss per share (vs UK£0.005 loss in 2Q 2022)

Independent Non-Executive Director recently bought €86k worth of stock

First quarter 2023 earnings released: UK£0.002 loss per share (vs UK£0.008 loss in 1Q 2022)

Forecast to breakeven in 2025

Less than half of directors are independent

Benchmark Holdings plc to Report Q3, 2023 Results on Aug 23, 2023

Benchmark Holdings plc has completed a Follow-on Equity Offering in the amount of NOK 158.437575 million.

Benchmark Holdings plc has completed a Follow-on Equity Offering in the amount of NOK 158.437575 million.

Benchmark Holdings plc, Annual General Meeting, Dec 16, 2023

Forecast to breakeven in 2024

Benchmark Holdings plc to Report Q4, 2022 Results on Nov 30, 2022

Less than half of directors are independent

Forecast to breakeven in 2025

Third quarter 2022 earnings released: UK£0.019 loss per share (vs UK£0.004 loss in 3Q 2021)

Benchmark Holdings plc to Report Q3, 2022 Results on Aug 25, 2022

Second quarter 2022 earnings released

Less than half of directors are independent

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Benchmark Holdings plc to Report Q1, 2022 Results on Feb 22, 2022

No longer forecast to breakeven

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Benchmark Holdings plc Announces Environmental Recognition for CleanTreat®

Forecast to breakeven in 2023

Benchmark Holdings plc Provides Revenue Guidance for the Second Half of 2021

Third quarter 2021 earnings released: UK£0.004 loss per share (vs UK£0.008 loss in 3Q 2020)

No longer forecast to breakeven

Second quarter 2021 earnings released: UK£0.005 loss per share (vs UK£0.023 loss in 2Q 2020)

Benchmark Holdings plc Provides Revenue Guidance for the Second Half of 2021

Independent Non-Executive Director recently bought €138k worth of stock

First quarter 2021 earnings released: UK£0.001 loss per share (vs UK£0.01 loss in 1Q 2020)

Revenue beats expectations

Independent Non-Executive Director has left the company

Benchmark Holdings plc to Report Q1, 2021 Results on Feb 22, 2021

New 90-day high: €0.71

Benchmark Holdings plc, Annual General Meeting, Feb 09, 2021

Full year 2020 earnings released: UK£0.038 loss per share

Revenue misses expectations

Hugo Wahnish Intends to Resign as Non-Executive Director of Benchmark Holdings plc, Effective February 9, 2021

New 90-day high: €0.58

Benchmark Holdings plc to Report Fiscal Year 2020 Results on Nov 27, 2020

New 90-day high: €0.53

CEO & Director recently bought €93k worth of stock

Third quarter earnings released

The management team of FAI Farms acquired FAI Farms Ltd from Benchmark Holdings plc (AIM:BMK) in management buyout transaction.

New 90-day high - €0.48

Benchmark Holdings plc to Report Q3, 2020 Results on Aug 28, 2020

Cell And Gene Therapy Catapult completed the acquisition of the vaccine manufacturing facility at Braintree from Benchmark Holdings plc (AIM:BMK).

New 90-day high - €0.45

Cell And Gene Therapy Catapult signed an agreement to acquire vaccine manufacturing facility at Braintree from Benchmark Holdings plc (AIM:BMK) for £12 million.